Ilan Sobel on Executing the “Scale-Up” | The CSE Podcast Ep2-S3

We start our second show of the season by revisiting one of the most memorable interviews from last season with Ilan Sobel, CEO of BioHarvest Sciences (CSE:BHSC). On last year’s interview we learned about the driving mission of his company to build “human utility value”. We use that as a jumping-off point as we re-unite after a notable year for the company despite global and economic headwinds.

Ilan provides an update on BioHarvest’s two key product verticals in the  Polyphenol and Cannabis sectors, and how each are taking unique (and in some cases, similar) paths to market. Ilan also reflects on some of the choices the company has made with respect to developing its sales funnel and shares valuable lessons about acting as a “learning” organization and listening to your customers.

Mr. Sobel is Chief Executive officer of  BioHarvest Sciences Inc. (CSE:BHSC)  –  the developer and exclusive owner of the proprietary and patent-protected BioFarming technology. It is the first and only industrial-scale plant cell technology capable of producing the active plant ingredients without the necessity to grow the plant itself. The Company’s technology is non-GMO and has already been validated by VINIA®, the red grapes cells functional food/dietary supplement produced and sold by BioHarvest Sciences Inc. The Company plans to generate significant revenue within the global nutraceutical ingredients and dietary supplements market with VINIA® and other Super Fruit Nutraceutical products. Further, by adapting this technology to the Cannabis plant, and building adequate production capacity, BioHarvest Sciences Inc.’s objective is to become a leading supplier of Cannabis for both medicinal and legal recreational purposes.

Learn more about BioHarvest Sciences at https://bioharvest.com/

Subscribe: Apple Podcasts / Spotify / Stitcher / Google Podcasts / iHeart / RSS